RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis. - Wikidata - awgldk - TriplyDB

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

http://www.wikidata.org/entity/Q40726435

about

Targeting dendritic cell function during systemic autoimmunity to restore tolerance Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway Tolerogenic dendritic cells as a target for the therapy of immune thrombocytopenia.In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae.Immune checkpoint receptors in regulating immune reactivity in rheumatic disease.β2-adrenoceptor signaling reduction in dendritic cells is involved in the inflammatory response in adjuvant-induced arthritic rats.The Interaction Between Allelic Variants of CD86 and CD40LG: A Common Risk Factor of Allergic Asthma and Rheumatoid Arthritis.Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC.Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.CD154: the atherosclerotic risk factor in rheumatoid arthritis?Signaling mechanisms regulating B-lymphocyte activation and tolerance.Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance.Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model.Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis.

P2860

Q27687098-4DD9D9A1-81D2-4C42-B44C-D872814D780C Q28080920-406AB0B6-2CB0-4BED-82A7-80DA7D1321AF Q28488150-1F2169D8-144C-450B-804F-B72D15D9F71B Q33400059-D0232437-29CF-4CF3-B068-BCE5ACD271A1 Q33863257-E1E2B4F2-F9B3-4FA1-8E12-6385104D775C Q34897654-7C23765B-C31F-4857-B49C-AC36BACE78B8 Q36799661-E141244D-AFB2-43EC-A424-3B7260DC3153 Q37605434-07ED0EF6-A5A7-4A50-8447-DB48EC92E76A Q37661080-A959CE4F-845B-4FDE-A24C-10E372B3348B Q37929646-EA08E314-B668-4A65-AD39-C4594C5A868D Q38083874-5F1AF284-2296-4FE1-AB2D-F31480364A5D Q38334794-279A787D-F428-437B-B933-6532DBD80505 Q38445344-12D39C8E-2D8B-4C64-A6B1-435ACF839DC8 Q39301153-7E23A303-0459-43F6-AF92-1BDF5466E579 Q42245452-A31A0CC0-3E66-48B8-9635-4B4053C7DF6A Q42593149-F63B3047-6C42-4CEF-B410-9BCB062D20CF Q42608288-88A67B9D-FD29-4C54-8B07-61151FD2CE11

P2860

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

http://www.wikidata.org/entity/Q40726435

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

@en

type

label

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

@en

prefLabel

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

@en

P1433

Q40726435-E444807C-9C33-4418-BDB7-DCC00D0A17BC

P1476

Q40726435-56F2E0E1-A73E-404C-B750-1AF75B3E5AD8

P2093

Q40726435-063411B5-F9ED-4402-9FB1-EB33F960229C

Q40726435-12E62ECC-5EA2-411C-A429-56D5F9F8FE09

Q40726435-2309B7B8-75A6-4DF1-93FB-177009BB65CB

Q40726435-29BAB281-1951-49BA-9CCB-DBABA1DC35A4

Q40726435-43E83495-04EC-4E7B-8F89-15D3E7175F52

Q40726435-5409A571-B038-4A2A-8F27-C38F3F243C36

Q40726435-7CB60937-2566-43D3-9B04-A2589AB50A18

Q40726435-BBAEE45C-490D-4489-892F-040F659F65DD

Q40726435-CAF9C190-B0D0-4A97-8077-D3FE75E70A33

Q40726435-F47F2E96-6991-40ED-9791-3FA68EE1686D

P2860

Q40726435-1F4DE9EA-1ECD-4C2D-8930-8080323BC8E0

Q40726435-20D5E37B-1928-4BFF-A14B-2387C0D30C3B

Q40726435-29E002B8-43B1-46ED-9C3E-0E2D4671B77A

Q40726435-39103B3C-8DEB-4175-B432-2B49ED40BCB3

Q40726435-46CEAE07-B4B4-48D5-8BE9-1DC6E513D4AB

Q40726435-488E7C3A-D58D-4DD6-8DE2-1B9A95F6E62F

Q40726435-6B60C6D6-E1B8-4CAF-8F47-EE4C56915AF1

Q40726435-7583F13E-4A45-4C2E-A2F0-6BA123932713

Q40726435-84C7FDC4-9544-4D50-8641-5BCA26DBCA59

Q40726435-8F148D24-9A98-40C4-B0C4-8926370E29EB

P2888

Q40726435-12E60260-539F-4E8F-A795-16BB9A509252

P304

Q40726435-46B45F2C-2A5C-4DB9-8220-193908C3C302

P31

Q40726435-DCB92D59-1569-48DE-BDD6-7073C2F7D519

P356

Q40726435-F37A3AC8-55EA-4611-A3B8-8225E5DDEF2F

P433

Q40726435-299B396A-4C9E-4552-B4E8-5122169C0A0B

P478

Q40726435-31C63512-8F3D-475A-9AD7-20A585A4146D

P577

Q40726435-87CE6986-D4AC-4EE1-B761-140D3E0B8BCD

P5875

Q40726435-3C26AE49-29BD-4AB6-90B5-1852802F3222

P6179

Q40726435-A0E25C1D-4777-4594-8F08-68DC93846B17

P698

Q40726435-9B191DFA-B785-44BF-A5C6-CC0C1A6C77BB

P932

Q40726435-2537820D-09EB-4DFF-A709-4A10B314C4A8

P356

P1433

Arthritis Research and Therapy

P1476

RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

@en

P2093

Aminah Shunnar

http://www.w3.org/2001/XMLSchema#string

Bertha Garcia

http://www.w3.org/2001/XMLSchema#string

Fei Zhu

http://www.w3.org/2001/XMLSchema#string

Hong Ling

http://www.w3.org/2001/XMLSchema#string

Michael H Wang

http://www.w3.org/2001/XMLSchema#string

Motohiko Suzuki

http://www.w3.org/2001/XMLSchema#string

Robert D Inman

http://www.w3.org/2001/XMLSchema#string

Thomas E Ichim

http://www.w3.org/2001/XMLSchema#string

Wei-Ping Min

http://www.w3.org/2001/XMLSchema#string

Xiufen Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine

Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance.

Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.

Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.

Oral tolerance in the treatment of rheumatoid arthritis.

CD40/CD154 interactions at the interface of tolerance and immunity.

Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target.

The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.

Tolerogenic dendritic cells for autoimmune disease and transplantation.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

P2888

P304

R13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2914

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41147626

http://www.w3.org/2001/XMLSchema#string

P6179

1006837997

http://www.w3.org/2001/XMLSchema#string

P698

20102615

http://www.w3.org/2001/XMLSchema#string

P932

2875641

http://www.w3.org/2001/XMLSchema#string